ALKEM.NS

Alkem Laboratories Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$5,334.00

Jun 15, 2026

AI Brief

Market cap

$640.45B

52w range

—

P / E

—

EPS · FY 2026

$192.51

Volume

—

Revenue · FY 2026

$147.12B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Alkem Laboratories Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$5334.00

Change

-4.15%

Period high

$5890.00

Period low

$5144.50

Period start

$5565.002026-02-01

Through 2026-06-15

Fair value

Football field →

Weighted blend

$4,230.50

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

ALKEM.NS

5,334-4.15%

H 5,915L 5,075MA50 5,400MA200 —Avg vol 135K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Utilities
+3.33%
Financial Services
+0.02%
Industrials
-0.12%
Healthcare
-0.72%
Energy
-0.94%
Technology
-0.95%
Consumer Defensive
-1.52%
Basic Materials
-1.60%
Consumer Cyclical
-1.74%
Communication Services
-1.79%
Real Estate
-2.19%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
-0.99%
Auto - Dealerships
-6.22%
Trucking
-5.25%
Renewable Utilities
+5.11%
Oil & Gas Energy
-4.86%
Consulting Services
-4.82%
Financial - Mortgages
-4.15%
REIT - Office
-3.71%
Software - Application
-3.50%
Medical - Healthcare Information Services
-3.48%
Grocery Stores
-3.45%
Discount Stores
-3.44%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for ALKEM.NS.

Peers

No peer list available for ALKEM.NS.

Total assets

$208.73B

Total debt

$20.47B

Cash & equiv

$2.48B

Operating CF

$19.63B

Free cash flow

$13.46B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$147.12B	$26.23B	$23.02B	$192.51	+15.65%